Tenaya Therapeutics股价在盘前下跌3.9% 因美国FDA对公司稀有心脏病基因治疗试验处于临床暂停状态

美股速递
Nov 10, 2025

Tenaya Therapeutics股价在盘前下跌3.9%,原因是美国FDA对该公司针对稀有心脏病的基因治疗试验实施了临床暂停。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10